Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | PGR | P06401 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.61 |
| ▸ | AR | P10275 | 1/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 7/20 | 0.53 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11546281 | 1.00 | HPGD (0.61) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL809252 | 1.00 | HPGD (0.61) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL29384474 | 1.00 | HPGD (0.61) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL9869694 | 1.00 | HPGD (0.61) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL29504864 | 1.00 | HPGD (0.61) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL9869466 | 1.00 | HPGD (0.61) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL27997232 | 0.96 | PTPN11 (0.59) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL27997262 | 0.96 | PTPN11 (0.59) | HPGDLMNACYP1A2PGRCYP3A4 | |
| SCHEMBL6662580 | 0.96 | HPGD (0.66) | HPGDLMNACYP1A2PGRCYP3A4 | |
| Octabenzone SCHEMBL7051498 | 0.94 | HPGD (0.59) | HPGDLMNACYP1A2PGRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0953595-A1 | UV light stabilized polyester molding composition | HOECHST CELANESE CORPORATION (US) | 1999-11-03 | — | — | EP | claimed |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-07 | — | — | US | disclosed |
| EP-3452528-B1 | METHOD FOR PRODUCING A POLYISOCYANURATE COMPOSITE MATERIAL | COVESTRO DEUTSCHLAND AG (DE) | 2025-07-30 | — | — | EP | disclosed |
| US-12331214-B2 | Resistant 2K-PUR coatings | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2025-06-17 | — | — | US | disclosed |
| EP-3953407-B1 | 2-COMPONENT POLYURETHANE COATINGS WITH IMPROVED POT LIFE WITHOUT LOST WEATHERING STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-3994192-B1 | RESISTANT 2K-PUR COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-4058499-B1 | POLYSILOXANE FUNCTIONALIZED POLYURETHANES FOR ENHANCING HYDROPHOBISATION OF SURFACES | COVESTRO DEUTSCHLAND AG (DE) | 2024-12-04 | — | — | EP | disclosed |
| EP-3554787-B1 | METHOD FOR PRODUCING A 3D PRINTED FOAM-FILLED OBJECT | STRATASYS INC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-3694897-B1 | METHOD FOR PRODUCING A CROSSLINKABLE POLYMER WITH FORMATION OF OXAZOLIDINONES | STRATASYS INC (US) | 2024-09-11 | — | — | EP | disclosed |
| US-20240294798-A1 | Coating Agents and Coatings That Are Obtainable Therefrom and Have Improved Resistance to Soiling and (Self-) Cleaning Properties | COVESTRO DEUTSCHLAND AG (DE) | 2024-09-05 | — | — | US | disclosed |
| EP-0007502-A1 | Process for preparing foamed moulded materials | BAYER AG (DE) | 1980-02-06 | — | — | EP | disclosed |
| US-4179432-A | 2-HYDROXYBENZOPHENONE, ORGANOTIN MERCAPTIDE PHOTOSTABILITY | CINCINNATI MILACRON CHEMICALS, INC. (US) | 1979-12-18 | — | — | US | disclosed |
| EP-0001965-A1 | Process for the preparation of foamed materials | BAYER AG (DE) | 1979-05-30 | — | — | EP | disclosed |
| US-4123418-A | BIS-(U8I8I8L8L-PENTAMETHY TETRAMETHYL-4-PIPERIDYL)-SUBERATE | CIBA-GEIGY CORPORATION (US) | 1978-10-31 | — | — | US | disclosed |
| US-4110304-A | STERICALLY HINDERED CYCLIC AMINE | CIBA-GEIGY CORPORATION (US) | 1978-08-29 | — | — | US | disclosed |
| US-4061631-A | STABILIZER | CIBA-GEIGY CORPORATION (US) | 1977-12-06 | — | — | US | disclosed |
| US-4012399-A | ULTRAVIOLET LIGHT ABSORBERS AND STABILIZERS | CINCINNATI MILACRON CHEMICALS, INC. (US) | 1977-03-15 | — | — | US | disclosed |
| US-4000101-A | POLYPROPYLENE | WESTON CHEMICAL CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-3959220-A | Polymer additives comprising transition metal complexes with trivalent phosphorous compounds | CINCINNATI MILACRON CHEMICALS, INC. (US) | 1976-05-25 | — | — | US | disclosed |
| US-3943098-A | 1-Aza-4-thiacyclohexane-4,4-dioxide derivatives and their use as agents protecting against light rays | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | TST, C9, ESD | HPGD 2313/4885LMNA 4756/4885CYP1A2 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.